Indian Company Master Data Made Simple
Olumpus Pharmaceuticals Private Limited
Olumpus Pharmaceuticals Private Limited, formed in 2003, has been in existence for 2. Olumpus Pharmaceuticals Private Limited holds the CIN U24230MH2003PTC140321 and registration number 140321. The organization is recorded as company limited by shares under Indian company law. The company has an authorized share capital of βΉ1.00 lakh. Its paid up capital is βΉ1.00 lakh.
Its principal business sector is manufacture of other chemical products. This entity is registered in Mumbai, India. The registered address is listed as A-1/3 3 Sneh Co Op Hus Socplot No 16 Sector 19a Nerul Navi Mumbai Mh 400706 In. According to the registry, the company is now under strike-off status. The companyβs official contact email is -.
Company Overview
- CIN
- Date of Incorporation
- 06/05/2003
- Company Status
- Strike Off
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- -
- Company Category
- Company limited by Shares
- Company Sub Category
- Non-govt company
- Listed in Stock Exchange
- No
- Class of Company
- Private Limited Company
- LEI Number
- Authorized Capital
- βΉ1,00,000.00
- Paid up Capital
- βΉ1,00,000.00
- Activity
- Manufacture of other chemical products
- -
- PAN
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Agrimmcor Limited | U24230AP1971PLC001455 | Mangalagiri Road,p.o. Box No.15, Mangalagiri Road, Guntur, Andhra Pradesh, India, 522001 |
| Coastal Chemical Company Pvt. Ltd. | U24230AP1967PTC011169 | 2flat No.a-2, Jyothi Apartments, Brindvan Colony Vijayaw Ada - 10. Ap 000000 In |
| Coastel Drugs And Pharmaceuiticals Pvt.ltd. | U24230AP1981PTC003314 | 18-250,shyamalanagar,,rajamundry,a.p. Ap 000000 In |
| Subhag Pharma Private Limited | U24230AP1983PTC003870 | 5/86, Sirinagar,vijayawada,andhra Pradesh,520007-india |
| Travar Distilleries Pvt Ltd | U24230AP1980PTC002643 | 40/421-1, Bhaskar Nagar,kurnool,na,andhra Pradesh,000000-india |
Address
FAQ
The current board member of Olumpus Pharmaceuticals Private Limited are: